Phibro Animal Health Corporation re-affirmed earnings guidance for the fiscal year 2022. Looking at net sales, again, up to $890 million to $920 million as guidance.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.91 USD | +0.96% |
|
+3.57% | +54.02% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.02% | 719M | |
+21.38% | 8.99B | |
+21.12% | 3.55B | |
-2.09% | 3.13B | |
+17.40% | 1.73B | |
-7.03% | 1.23B | |
-30.45% | 1.13B | |
-33.39% | 1.11B | |
-23.95% | 975M | |
+2.77% | 950M |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Re-Affirms Earnings Guidance for the Fiscal Year 2022